A description of the two lung cohorts is presented in Table 1.In the Greek cohort (training set), SOX2 levels were measured in 340 lung carcinomas, including 167 (49.12%) SCC,133 (39.12%) ADC, and 40 (11.76%) cases corresponding to other carcinoma subtypes. Here, SOX2 is linked to carcinoma.